Anavex Life Sciences Corp (AVXL)

[XenaLives]

I think we're going to have to study all of this for a while to figure out the full meaning of this presentation.

First of all - Anavex is proposing restoration of these microbiota as a biomarker for recovery.

I think what may be going on here is that the accumulation toxic waste in the system suppresses the microbiome and restoration of homeostasis allows it to recover.

I also think it's possible that Eisai's plaque drug will need a 2-73 assist if it is to do anything.

So the correct answer may be "both", that as the gut recovers 2-73 begins to work better. I really don't know yet.